A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus

Mise à jour : Il y a 4 ans
Référence : NCT00044135

Femme et Homme

Extrait

The purpose of the study is to evaluate the safety and effectiveness of 12 weeks of treatment with clevudine, at one of three doses, in patients chronically infected with hepatitis B virus.


Critère d'inclusion

  • Hepatitis B


Liens